Xencor, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (30)

Latest Posts

About This Stock More About This Stock
Week In Review: Shanghai's Zenas Acquires CD19 Antibody From Xenco In $480 Million Deal
Article By: ChinaBio® Today
Saturday, November 27, 2021 2:30 PM EDT
In a $480 million deal, Zenas acquired global rights to a bifunctional antibody from Xencor that targets CD19. Instead of an upfront payment, Zenas will issue a warrant granting Xencor the right to acquire Zenas shares up to 15% of Zenas’ equity.
In this article: 600276.SS, XNCR, BGNE, TCON, 2616.HK, 9966.HK, 2096.HK
Read
The Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates
Article By: Benzinga
Saturday, September 26, 2020 3:55 PM EDT
Biotech stocks reversed course last week, dragged lower by the broader market weakness. The week's news flow was headlined by Johnson & Johnson kickstarting a Phase 3 trial of its coronavirus vaccine candidate.
In this article: JNJ, CAPR, XNCR, MESO, ACIU, SBPH, VCNX, AQST, MGTX, ETON
Read
Biotech Portfolio Review: What To Do Next?
Article By: Rod Raynovich
Sunday, July 19, 2020 11:53 AM EDT
Your biotech portfolio is probably up at least 10% YTD because the IBB is up ~17% and the XBI up 18.35%. Do you raise cash or go more defensive with the life science positions you own?
In this article: IBB, XBI Also: AZN, BMY, JNJ, MRK, UNH, RHHBY, FBIOX, FSMEX, GILD, FBT, GLD, ABBV, XNCR, TDOC, CRSP
Read
TalkMarkets Tuesday Talk: May Market Maze
Article By: TalkMarkets DailyTalk
Tuesday, May 26, 2020 6:36 AM EDT
It's the last Tuesday in May and the start of a short trading week to end out the month, and what the week will look like is anyone's guess. With US-China tensions rising, a mix of good and bad news is sure to send the charts up and down.
In this article: BRK-A, EPR, KMI, MAIN, IBB, AAPL, VNQ, XBI, XNCR, STNE, VIR
Read
What’s Next For The Biotech Bull Market? Are You A Trader Or An Investor?
Article By: Rod Raynovich
Tuesday, May 26, 2020 1:57 AM EDT
Despite the economic pains of the pandemic, investors are driven to life science companies in the news with potential solutions for COVID-19. The potential for a COVID-19 vaccine or a new viral diagnostic product has been the focus of the market.
In this article: BMY, MRK, RHHBY, FBIOX, IBB, ILMN, INCY, QQQ, REGN, SGEN, GILD, NBIX, PACB, VRTX, AMRN, GDX, XBI, XNCR, TDOC, EDIT, NTLA, CRSP, VIR, ABBV, PRHSX, IDXX
Read

Latest Tweets for $XNCR

No tweets yet!

PARTNER HEADLINES